FDA Approval of Jemperli for Endometrial Cancer Treatment

The FDA has approved a new immunotherapy drug called Jemperli for certain adult patients with endometrial cancer. This is the third FDA approval this year for immunotherapy in endometrial cancer, showing improved outcomes for patients.

Australian doctor's successful treatment of terminal brain tumor

Australian doctor diagnosed with terminal brain tumor last year is cancer-free thanks to a first-of-its-kind treatment he helped develop. Treatment included immunotherapy, combination of drugs before and after surgery, vaccine tailored to tumor's characteristics, and radiotherapy.

mRNA Cancer Vaccine Shows Promise in Treating Aggressive Brain Tumours

A new mRNA cancer vaccine has shown promising results in reprogramming the immune system to attack tumours within 48 hours. The vaccine has been tested in a human clinical trial with positive outcomes, potentially opening new treatment avenues for aggressive brain tumours.

Advancements in Lung Cancer Treatment and Survival Rates

Denise Lee shares her journey of battling lung cancer, caught early through screening and treated with surgery, immunotherapy, and other advancements in medicine, leading to her remission and survival for six years. New treatments and technology have significantly improved survival rates for lung cancer patients.